August 12, 2020
Coronavirus

FOX NEWS: Doctor suggests salt to help fight COVID-19

coronavirus, COVID-19, covid19

Dr. Steven Quay suggests a novel method to enhance mask protection against germs amid the COVID-19 pandemic. By spraying a salt solution onto masks and letting it dry overnight, studies have shown up to a thousand-fold improvement in virus stopping ability.

The idea, detailed in Dr. Quay’s book “The COVID-19 Survival Guide,” involves salt crystals dissolving droplets containing viruses, ultimately leading to their destruction. The solution also includes a small amount of dish soap to further disrupt the virus’s fatty surface.

Although not specifically tested against COVID-19, the method offers an additional layer of protection and peace of mind. The recipe for the solution involves water, salt, and dish soap, with careful preparation and application instructions provided. While there’s no definitive proof of its effectiveness against COVID-19, it presents a potential way to bolster mask protection.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer

October 31, 2024

This video describes the clinical data from the Atossa Therapeutics press release of October 31, 2024 entitled, Atossa Therapeutics Releases Promising Preliminary Analysis Demonstrating (Z)-Endoxifen’s Potential to Rapidly Reduce Ki-67 and Tumor Volume in ER+/HER2- Breast Cancer

Dr. Quay featured in CBS7 on New 2024 COVID Vaccine

September 4, 2024

This summer saw a rise in COVID-19 infections across the U.S., driven by a new variant. To address this, updated vaccines from Moderna and Pfizer have been approved by the FDA and will be available this fall. The CDC notes the virus has been evolving, making regular vaccinations important, especially for those with underlying health conditions.

Lanzamiento de la Nueva Vacuna contra el COVID-19: Lo Que Necesitas Saber para el Otoño de 2024

August 31, 2024

Los casos de COVID-19 están aumentando ligeramente en EE. UU., y se introducirá una nueva vacuna este otoño. Telemundo20 en Texas conversa con el Dr. Quay para discutir los datos más recientes sobre esta vacuna y las precauciones que las personas deben considerar para los próximos meses. A pesar de la presencia continua del virus, actualmente es menos infeccioso y se asemeja a un resfriado común en términos de transmisión.

Join Dr. Quay’s ElevatorMedicine™ and get FREE, QUICK TIPS for better living, health, and wellness that take less time than riding an elevator!